Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $24.2 million.

Aspen Aerogels sees FY2014 EPS of ($5.38)-($5.34), versus prior guidance of ($5.45)-($5.55) and the consensus of ($5.51). Aspen Aerogels sees FY2014 revenue of $100-102 million, versus prior guidance of $98.5-101.5 million and the consensus of $98.81 million.

Aspen Aerogels sees FY2015 EPS of ($0.31)-($0.43), versus the consensus of ($0.18). Aspen Aerogels sees FY2015 revenue of $113-117 million, versus the consensus of $116.12 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.